Stock price & ticker
Dividend & net profit
Questions? We're here to help
The CellaVision share has been listed on the NASDAQ Stockholm, Mid Cap since 2018. Learn more about the CellaVision share here.
CellaVision is committed to the corporate governance principles to promote business competitiveness and investor confidence.
We help hematology laboratories automate and simplify the process of performing blood and body fluid differentials.